梅州急性附件炎诊治去哪里梅州三个月人流的价格,梅州白带异常会有什么后果,梅州妇科较好的医院,梅州怎样诊疗真菌阴道炎,梅州那几家妇科医院比较好,梅州病毒性阴道炎的治疗,梅州超导可视打胎术大概要多少钱

HAVANA, Sept. 6 (Xinhua) -- Cuban medical authorities have launched the sales of the world's first therapeutic vaccine against lung cancer, local officials said on Tuesday.The CimaVax-EGF vaccine, as a result of a 25-year research into diseases related to tobacco smoking, has been developed by researchers and scientists at the Center of Molecular Immunology (CIM) in Havana.The active drug ingredient in the vaccine is based on "a protein we all have when cancer is uncontrolled." "The epidermal growth factor is related to all cell proliferation," said Gisela Gonzalez, head researcher of the project."The drug could turn the cancer into a manageable, chronic disease by generating antibodies against the proteins which triggered the uncontrolled cell proliferation," she said.The immunogenic vaccine is appropriate to patients with advanced lung cancer in stages of three and four, showing no positive response to other kinds of treatments such as chemotherapy and radiotherapy, the expert said."It is not possible to prevent the disease but this vaccine improves significantly the status of the critically ill patients," she added.She said the CimaVax-EGF has gone through clinical studies and trials in over 1,000 patients across the island and is currently distributed free of charge in all hospitals of the Caribbean island nation.Gonzalez also said researchers at the CIM planned to use the same principle of the CimaVax-EGF in treating other cancerous tumors such as prostate, uterus and breast cancers.Lung cancer is regarded as one of the world's most serious, common and deadly cancers and is most frequently found among tobacco smokers.According to the World Health Organization, the disease generally kills 5 million people a year, and the figure is expected to rise to as much as 8 million by 2030 unless smoking habits are changed.In Cuba, like many other developing countries across the world, smoking is seen as a status symbol. Lung cancer, killing about 20,000 people a year in the Caribbean country, is considered a serious threat to public health and the leading cause of death in 12 of the country's 15 provinces.

LOS ANGELES, July 28 (Xinhua) -- Mainly due to rampant obesity, Americans' life expectancy is one-and-a-half-year shorter than that of Western Europeans on the average, according to a new study published on Thursday.But 40 years ago, Americans could expect to live slightly longer than Europeans, said the study jointly conducted by researchers from University of Southern California (USC), the Harvard School of Public Health and the RAND Corp., a non-profit think tank.In addition to Western Europeans, Americans also die younger than the residents of most other developed nations, according to the study appearing in the July issue of Social Science & Medicine.The life-expectancy disparity, which begins around the age of 50, stems from higher levels of middle-age obesity and obesity-related chronic diseases, such as hypertension and diabetes, said the study.In the first half of the last century, average life expectancy increased by saving more babies, said author Dana Goldman, director of the Schaeffer Center for Health Policy and Economics at the USC."But now it is reduction in mortality among the elderly, rather than the young, that propels increases in life expectancy," he said. "The question is whether 'being American' is an independent mortality risk factor."If 50-year-old U.S. adults could be as healthy as Europeans, it could save Medicare and Medicaid 632 billion dollars by 2050, the study said.Though the transition to better health initially raises expenditures, the researchers estimate that by 2050 healthcare savings from health improvements among the middle age could total more than 1.1 trillion dollars."The international life expectancy gap appears much easier to explain than gaps within countries: there is no American-specific effect on longevity beyond differences in disease at age 50," said Darius Lakdawalla, an associate professor in the USC School of Policy, Planning and Development.

KATHMANDU, Aug. 3 (Xinhua) -- Two glaciers in Nepal that shrank at an accelerated rate in the past 10 years compared to preceding decades will inevitably disappear from rising temperatures as no fresh snow supply is expected for them, a new research by Japan's Nagoya University says.According to Wednesday's Republica daily, the masses of the Yala glacier of Langtang Himal in central Nepal and the AX010 glacier of Shorong Himal in the Khumbu region shrank annually by 0. 8 meters and 0.81 meters respectively in the 2000s, which was a significant acceleration from the 0.68 and 0.72 meters of shrinkage per year between 1970 and 1990, said findings of the research published in a journal of the National Academy of Sciences of the United States on Tuesday."If the trend since the 1990s continues for the Yala and AX010 glaciers, the disappearance of these glaciers is inevitable because they are about to lose their accumulation areas, thus, no snow supply is expected for these glaciers," says the research conducted by Koji Fujita and Takayuki Nuimura.The researchers also found that while the shrinking of glaciers has accelerated in humid environments, the opposite is true for those in arid environments. The shrinking of Rikha Samba glacier located in the Kaligandaki Hidden Valley slowed from 0.57 meters per year between 1970 and 1990 to 0.48 meters per year in the 2000s."A comparison of the mass balance results and annual precipitation reveals that glacier wastage has been accelerated in humid environments but suppressed in an arid environment," the research says.Apart from environment, altitude also appears to play a role in the lifespan of glaciers, the researchers say. Rikha Samba is located at an altitude of 5,700 meters where loss of mass from melting could be compensated to some extent by collection of snowfall.The Yala glacier and AX010, on the other hand, are located at lower altitudes of 5,400 meters and 5,200 meters respectively.

BEIJING, July 5 (Xinhuanet) -- Facebook CEO Mark Zuckerberg confirmed that he has signed up to Google+, the new social networking platform from Google, according to media reports Tuesday.Launched last month, Google+ is the Internet giant's latest foray into social networking.Zuckerberg confirmed that the profile with his name on Google+ belongs to him only, and said, "Why are people so surprised that I'd have a Google account?" Facebook CEO Mark Zuckerberg reacts after unveiling a new messaging system during a news conference in San Francisco, California November 15, 2010.In social networking field, it is rare for someone to join the rival's platform, therefore, Zuckerberg's move is considered strange.But interestingly, Zuckerberg has more followers than Google founders Larry Page and Sergey Brin, and even Vic Gundotra, the man behind Google+, with over 21,000 people.Besides Google+, Zuckerberg also has an account on Twitter, though it has not been updated for some time.

KIEV, Aug. 2 (Xinhua) -- Ukraine's regional health authority declared Tuesday a cholera epidemic in the eastern region of Donetsk had ended.All 26 people who had been treated for the disease had been discharged from hospital, the press-service of the Donetsk Regional Sanitary and Epidemiological Service said on its official website.As of this week, no new cases had been registered, the statement said.The cholera outbreak hit eastern Ukraine in late May. The disease can cause rapid dehydration and death.The outbreak was believed to be associated with fish and drinking water supplies from the Sea of Azov.